Skip to content
Trial Eligibility
Menu

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

NCT06504160

This study is recruiting at 7 US sites in 6 states, according to its ClinicalTrials.gov record last updated .

Summary

This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and pediatric participants with atopic dermatitis. The primary safety objective of this study is to compare the safety profile of ShA9 to placebo (vehicle) over 14 weeks of application, which includes an initial two-week period of co-treatment with topical corticosteroids (TCS).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Atopic Dermatitis

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
6 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Last updated on ClinicalTrials.gov
July 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California, San Diego: Dermatology Clinical Trials Unit · San Diego, CA

Colorado · 1

  • National Jewish Health: Division of Pediatric Allergy and Clinical Immunology · Denver, CO

Illinois · 1

  • Northwestern University Feinberg School of Medicine: Department of Dermatology · Chicago, IL

New York · 2

  • Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology · New York, NY
  • University of Rochester Medical Center: Department of Dermatology · Rochester, NY

Ohio · 1

  • Cincinnati Children's Hospital Medical Center: Asthma Center · Cincinnati, OH

Wisconsin · 1

  • University of Wisconsin School of Medicine and Public Health: Division of Pediatric Allergy, Immunology and Rheumatology · Madison, WI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.